LFMD Q3 2018 Earnings — LifeMD, Inc. Revenue & Financial Results | Market Cap Arena

LFMDLifeMD, Inc.

$200M

Q3 2018 Earnings

Healthcare Medical - Pharmaceuticals

Income Statement

Revenue

$2M+21.6% YoY

Gross Profit

$2M82.4% margin

Operating Income

-$438,631-17.6% margin

Net Income

-$548,977-22.0% margin

EPS (Diluted)

$-0.06

QoQ Revenue Growth

+22.5%

Cash Flow

Operating Cash Flow

-$261,025

Free Cash Flow

-$261,025

Stock-Based Comp.

$171,451

Balance Sheet

Total Assets

$2M

Total Liabilities

$699,882

Stockholders' Equity

$1M

Cash & Equivalents

$407,272

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$2M	+21.6%
Gross Profit	$2M	$2M	+35.6%
Operating Income	-$438,631	-$273,567	-60.3%
Net Income	-$548,977	-$679,063	+19.2%